Iran vows to strike back if U.S. attacks
Tehran on Sunday threatened to retaliate against Israel and U.S. bases in the event of U.S. strikes on Iran.
Trump seeks to stop courts, creditors from seizing Venezuelan oil revenue in the U.S.
Any use of judicial process against the funds will interfere with efforts to “ensure economic and political stability in Venezuela,” the order says.
AI is helping recruiters find ‘hidden gem’ talent — a senior LinkedIn exec shares top tips to stand out
“2026 is the year of more widespread adoption of AI tools, particularly in hiring,” Janine Chamberlin, LinkedIn’s UK Country Manager told CNBC Make It.
Are we in an AI bubble? What 40 tech leaders and analysts are saying, in one chart
OpenAI and Nvidia have gone on a blitz of AI infrastructure deals while hyperscalers continue to spend billions in capex.
FCC approves SpaceX plan to deploy an additional 7,500 Starlink satellites
The FCC said Elon Musk’s SpaceX can now operate an additional 7,500 Gen2 Starlink satellites, bringing the total to 15,000 satellites worldwide.
Trump faces headwinds on Venezuela, health care as some Republicans break rank
A White House official said Republicans breaking with the president represent a “tiny fraction” of the congressional GOP.
How BlackRock, world’s largest asset manager, is fine-tuning market portfolios for 2026
Investing giant BlackRock expects bull market in AI stocks to extend in 2026, but says investors should focus on targeted bets and turning cash into income.
Behind Anthropic’s stunning growth is a sibling team that may hold the key to generative AI
Daniela Amodei has helped build Anthropic into a serious AI player by betting on safety and enterprise adoption.
2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
Activist Elliott shakes up leadership at Lululemon. How the firm can help reinvigorate the athleisure giant
Elliott has amassed a stake of more than $1 billion in Lululemon, and it has brought along Jane Nielsen as a potential CEO candidate.